PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Greenland's ice shelves have lost more than a third of their volume

Greenland's ice shelves have lost more than a third of their volume
2023-11-07
(Press-News.org)

The largest floating ice shelves in the polar ice sheet have lost more than a third of their volume since 1978. In a study to be published on 7 November in Nature Communications, scientists from the CNRS1, alongside their Danish and American colleagues, have established that most of this thinning is due to the rise in surrounding ocean temperatures, which causes the glaciers’ floating extensions to melt. Until now, the glaciers in this region were considered to be stable, unlike more sensitive areas of the polar ice cap, which began to weaken in the mid-1980s.

Located in North Greenland, these ice shelves play an essential role in regulating the amount of ice discharged into the ocean by acting as huge frozen “dams”. Although Greenland is already responsible for 17% of the current rise in sea levels, any weakening of these barriers could lead to an increase in the amount of ice released, accelerating further rises in the water level.

These results were obtained using field observations, aerial photography and satellite data, combined with regional climate models.

Notes

1 - Working at the Institut des géosciences de l’environnement (CNRS/Université Grenoble Alpes/IRD/Inrae/Grenoble INP).

END


[Attachments] See images for this press release:
Greenland's ice shelves have lost more than a third of their volume

ELSE PRESS RELEASES FROM THIS DATE:

COVID-19 hospitalization in solid organ transplant recipients on immunosuppressive therapy

2023-11-07
About The Study: The findings of this study suggest that maintenance immunosuppressive drugs are associated with an increased risk of COVID-19 hospitalization in solid organ transplant recipients. These results should be considered by clinicians treating transplant recipients and may help inform epidemic-related decisions for this population in the future. Authors: Epiphane Kolla, M.D., M.P.H., of French National Health Insurance in Saint-Denis, France, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi: 10.1001/jamanetworkopen.2023.42006) Editor’s ...

Presentation and outcomes of adults with overdose-related out-of-hospital cardiac arrest

2023-11-07
About The Study: In a population-based study of 6,790 adult patients with emergency medical services–treated out-of-hospital cardiac arrest (OHCA) from a U.S. metropolitan system, the incidence of overdose related out-of-hospital cardiac arrest increased significantly from 2015 to 2021. The greatest increase was observed among patients with a combined stimulant-opioid OHCA. Presentation and outcome differed according to the drug-specific profile. The combination of increasing incidence and lower survival among patients with an opioid-stimulant OHCA supports prevention and treatment initiatives ...

Africa’s dangerous air pollution levels are a global problem, says new research

2023-11-07
A new report in Nature Geoscience has brought to light the challenge of air pollution levels in Africa and why international action is needed to combat it.    Over the last 50 years African nations have suffered from rapidly deteriorating air quality, making their cities some of the most polluted in the world. Particulate matter concentration levels are now five to ten levels greater than that recommended by the World Health Organisation, with the situation predicted to worsen as populations grow and industrialization accelerates.   However, far too little has been ...

Body changes up to eight years before inflammatory bowel disease diagnosis

2023-11-07
Francis Crick Institute press release Under strict embargo: 16:00hrs GMT Tuesday 7 November 2023 Peer reviewed Observational study People Body changes up to eight years before inflammatory bowel disease diagnosis Researchers at the Francis Crick Institute and Aalborg University in Copenhagen have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease and up to three years before a diagnosis of ulcerative colitis. This means the beginnings of inflammatory bowel diseases start a long time before symptoms occur, and in the future may provide an opportunity for doctors to take preventative ...

When dads are feeling a bit depressed or anxious, how do kids fare?

2023-11-07
Many parents experience stress, anxiety, and depressive symptoms throughout their lives, particularly during times of transition, such as pregnancy and children’s entry into school. Studies have generally found that high levels of anxiety and depression in parents are linked to poorer behavioural and cognitive outcomes in children. A team of researchers led by Tina Montreuil, Associate Professor in McGill’s Department of Educational and Counselling Psychology and Scientist in the Child Health and Human ...

Screening sharply improves lung cancer long-term survival

Screening sharply improves lung cancer long-term survival
2023-11-07
OAK BROOK, Ill. – Diagnosing early-stage lung cancer with low-dose CT screening dramatically improves the long-term survival rate of cancer patients, according to a large-scale, 20-year international study published today in Radiology, a journal of the Radiological Society of North America (RSNA). The results show that patients diagnosed with lung cancer by low-dose CT screening have a 20-year survival rate of 81%. If diagnosed in the earliest Stage I, long-term survival was 95%. “It is the first time that 20-year survival rates ...

Lung cancer screening dramatically increases long-term survival rate

2023-11-07
New York, NY (November 7, 2023) — Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves its cure rate measured over a 20-year period, according to a large-scale international study by Mount Sinai researchers published in Radiology. The results show that patients diagnosed with lung cancer via CT screening have a 20-year survival rate—an approximation of the cure rate—of 81 percent. Among the 1,257 participants diagnosed with lung cancer, 81 percent ...

New strategy may halt tumors' aggressive response to glucose deprivation

2023-11-07
BACKGROUND One of the hallmarks of cancer cell development is its dependence on sugar, especially glucose, to grow and divide. Scientists have long been studying how to restrict or block this process that promotes tumor growth, called glycolysis, from happening as a possible effective strategy against cancer. Previously, researchers from the UCLA Health Jonsson Comprehensive Cancer Center identified a specific protein sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose. Drugs that inhibit SGLT2 are already FDA approved for other conditions and the UCLA team found these drugs could also delay the development ...

Giles Robinson, MD, named director of the Neuro-Oncology Division at St. Jude Children’s Research Hospital

Giles Robinson, MD, named director of the Neuro-Oncology Division at St. Jude Children’s Research Hospital
2023-11-07
St. Jude Children’s Research Hospital today announced Giles Robinson, M.D., has assumed the role of director for the Department of Oncology’s Division of Neuro-Oncology. He has also become co-leader of the Neurobiology and Brain Tumor Program within the St. Jude Comprehensive Cancer Center. These combined units comprise one of the largest clinical brain tumor programs in North America. “Dr. Robinson has been an exemplary member of St. Jude since joining as a hematology/oncology fellow in 2007,” said Julie R. Park, M.D., Department of Oncology ...

MD Anderson and Jazz Pharmaceuticals announce five-year collaboration to evaluate zanidatamab in HER2-expressing cancers

2023-11-07
HOUSTON and DUBLIN ― The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year strategic research collaboration agreement to evaluate zanidatamab, Jazz’s investigational HER2-targeted bispecific antibody, in multiple HER2-expressing cancers. The collaboration will combine MD Anderson’s translational medicine and clinical research expertise with Jazz’s expanding oncology drug development capabilities to investigate the potential of zanidatamab as monotherapy and in combination with other treatments for patients with different tumor types and stages. This includes its possible applicability ...

LAST 30 PRESS RELEASES:

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

American College of Cardiology issues guidance on weight management drugs

Understanding the effect of bedding on thermal insulation during sleep

Cosmic signal from the very early universe will help astronomers detect the first stars

With AI, researchers find increasing immune evasion in H5N1

Study finds hidden effects of wildfires on water systems

Airborne fungal spores may help predict COVID-19 & flu surges

Study shows tissues’ pliability depends on watery fluid between cells

Interfacial polymer cross-linking strategy enables ultra-thin polymeric membranes for fast and selective ion transport

A leap in canine medicine: Method for reproducible mesenchymal stem cells found

New nanoparticles offer safer, more effective drug delivery

Virtual reality could help stroke survivors regain movement

Placenta and hormone levels in the womb may have been key driver in human evolution, say researchers

BMJ finds inaccuracies in key studies for AstraZeneca’s blockbuster heart drug ticagrelor

Paper outlines more efficient organic photoredox catalysis system inspired by photosynthesis

Plastic bag bans: Study finds up to 47% drop in shoreline bag litter

Plastic bag policies are effective in reducing shoreline litter in the US

Current chemical monitoring data hinders global water risk evaluations

New method enables in vivo generation of CAR T cells to treat cancer and autoimmune disease

Decline in population data collection threatens global public policy

[Press-News.org] Greenland's ice shelves have lost more than a third of their volume